I get what you're saying but I don't think it's very wise to twist their arm into a massive increase.
If Merck sell what is essentially the same product for 600-800 dollars per 10 mil, why would Ellume want to pay 12.5-25x more?
It does enable their product, but having them pay so much more I don't think is realistic, unless Ellume want to be generous. But they are a business at the end of the day. And forcing them to pay a high price could push them to seek alternatives in future products.
I just don't see it happening. I certainly hope that I'm wrong though. I'm all for more money for ADO.
seizing the mkt opportunity/ current mkt conditions in the usa is a good example, page-4
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
-0.002(15.4%) |
Mkt cap ! $29.75M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.1¢ | $50.90K | 4.358M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 2060705 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 1259179 | 3 |
View Market Depth
| Last trade - 15.59pm 14/07/2025 (20 minute delay) ? |
| ADO (ASX) Chart |